EmeritusDX Announces Launch of UTIDX™ to Advance Patient Care in Urology

IRVINE, Calif.: IRVINE, Calif., Jan. 27, 2022 /PRNewswire-PRWeb/ -- EmeritusDX, a rapidly growing cancer diagnostics and information company, today announced the launch of UTIDX™, a PCR based test used for the diagnosis and treatment of Urinary Tract Infections (UTI). The test includes the top 31 uropathogens associated with UTIs, 24...

Click to view original post